Arteriovenous Fistulae in Chronic Kidney Disease and the Heart: Physiological, Histological, and Transcriptomic Characterization of a Novel Rat Model
Jef Van den Eynde,Xander Jacquemyn,Nicolas Cloet,Dries Noé,Hilde Gillijns,Marleen Lox,Willy Gsell,Uwe Himmelreich,Aernout Luttun,Keir McCutcheon,Stefan Janssens,Wouter Oosterlinck
DOI: https://doi.org/10.1161/JAHA.122.027593
2022-10-09
Abstract:Background Arteriovenous fistulae (AVFs) are the gold standard for vascular access in those requiring hemodialysis but may put an extra hemodynamic stress on the cardiovascular system. The complex interactions between the heart, kidney, and AVFs remain incompletely understood. Methods and Results We characterized a novel rat model of five‐sixths partial nephrectomy (NX) and AVFs. NX induced increases in urea, creatinine, and hippuric acid. The addition of an AVF (AVF+NX) further increased urea and a number of uremic toxins such as trimethylamine N‐oxide and led to increases in cardiac index, left and right ventricular volumes, and right ventricular mass. Plasma levels of uremic toxins correlated well with ventricular morphology and function. Heart transcriptomes identified altered expression of 8 genes following NX and 894 genes following AVF+NX, whereas 290 and 1431 genes were altered in the kidney transcriptomes, respectively. Gene ontology and Kyoto Encyclopedia of Genes and Genomes analysis revealed gene expression changes related to cell division and immune activation in both organs, suppression of ribosomes and transcriptional activity in the heart, and altered renin‐angiotensin signaling as well as chronodisruption in the kidney. All except the latter were worsened in AVF+NX compared with NX. Conclusions Inflammation and organ dysfunction in chronic kidney disease are exacerbated following AVF creation. Furthermore, our study provides important information for the discovery of novel biomarkers and therapeutic targets in the management of cardiorenal syndrome. Nonstandard Abbreviations and Acronyms AVF arteriovenous fistula KEGG Kyoto Encyclopedia of Genes and Genomes NX five‐sixths partial nephrectomy Clinical Perspective What Is New? A novel rat model was developed combining five‐sixths partial nephrectomy and an arteriovenous fistula to study the complex interactions between heart failure, chronic kidney disease, and hemodialysis vascular access. Based on a comprehensive serial physiological, histological, and transcriptomic assessment, we provide the first direct evidence that inflammation and organ dysfunction in chronic kidney disease are exacerbated following application of an arteriovenous fistula. What Are the Clinical Implications? The profound impact of the arteriovenous fistula on the heart and kidney observed in this study may help explain the increased cardiorenal morbidity and mortality observed in the population undergoing hemodialysis. This study provides important information for the discovery of novel biomarkers and therapeutic targets in the management of cardiorenal syndrome. Heart failure (HF) is a significant public health problem. Population‐based studies consistently show a prevalence 1.5% to 4% in developed countries 1 and estimate that this number will increase by 46% in 2030. 2 Despite improvements in diagnosis and management, costly hospitalizations for decompensated HF are common, and prognosis remains poor, with a 5‐year mortality rate around 40%. 3 The main barrier to improving outcomes are the comorbidities that many patients have, the most important being kidney dysfunction. According to a recent meta‐analysis, chronic kidney disease (CKD) is present in 49% of patients with HF and is associated with a 2.34‐fold higher risk of all‐cause mortality. 4 Furthermore, several clinical studies have demonstrated an exponential relationship between decreasing kidney function and cardiovascular mortality, even after adjustment for other established risk factors. 5 , 6 Based on preclinical observations, there is an emerging understanding that CKD is a chronic, systemic proinflammatory state that mimics accelerated aging of the cardiovascular system through tissue remodeling, vascular and valvular calcification, and cellular senescence. 7 The finding that cardiovascular and renal diseases are both common, often coexist, and perpetuate each other has led to the recognition of "cardiorenal syndrome" as a distinct clinical entity. 8 An especially challenging situation is presented when patients with end‐stag -Abstract Truncated-